Relmada Therapeutics Inc (RLMD)

0.3614 -0.02 (-4.79%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Relmada Therapeutics Price to Book Value: 0.229 for Dec. 24, 2024

Price to Book Value Chart

View Price to Book Value for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Ratio Definition

View Price to Book Ratio Definition
Start Trial

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Eli Lilly and Co 53.04
Sensei Biotherapeutics Inc 0.2495
NovaBay Pharmaceuticals Inc 2.474
Palatin Technologies Inc --
iBio Inc 1.245

Price to Book Value Related Metrics

PEG Ratio -0.101
Price 0.3614
Earnings Yield -791.4%
Market Cap 10.90M
PEGY Ratio -0.101